Status:
COMPLETED
Korean Red Ginseng and Metabolic Syndrome
Lead Sponsor:
The Korean Society of Ginseng
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Five factor consisting of Metabolic syndrome is closely linked by insulin resistance. Until now, several studies have been performed about effects of Korea red ginseng on hypertension, diabetes, and h...
Detailed Description
The details of study objective are followed by these: * comparison of blood pressure before and after Korean red ginseng administration * comparison of metabolic indicator before and after Korean red...
Eligibility Criteria
Inclusion
- (three or more of following five factors)
- waist circumference(male: more than 90cm, female: more than 80cm)
- blood pressure(systolic: more than 130mmHg, diastolic: more than 85mmHg)
- fasting plasma glucose: more than 100mg/dL
- fasting triglycerides: more than 150mg/dL
- High-density lipoprotein(HDL)-cholesterol(male: less than 40mg/dL, female: less than 50mg/dL)
Exclusion
- (any one of following factors)
- uncontrolled blood pressure(systolic: more than 160mmHg, diastolic: more than 100mmHg) or subjects taking blood pressure lowering drug
- Type 2 diabetes patients or fasting plasma glucose more than 126mg/dL
- triglyceride more than 400mg/dL, total cholesterol more than 250mg/dL
- subjects taking antilipidemic drug
- past history of coronary heart disease or cerebrovascular disease
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00976274
Start Date
August 1 2009
End Date
January 1 2011
Last Update
February 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei Univeristy College of Medicine, Gangnam Severance Hospital
Seoul, South Korea, 135-720